SPINAL CORD STIMULATION DEVICES MARKET

125 Pages | 34 Exhibits | 2018 Analysis | Forecasts Through 2022

OVERVIEW:
This analysis includes a discussion of current Spinal Cord Stimulation (SCS) devices, emerging innovative technologies, competitors, trends, and expected market growth. Market analysis includes a 5-year market forecast by region, drivers/limiters, estimated market share by region, and corporate strategies for success in one of the fastest medical device markets today.

SPINAL CORD STIMULATION DEVICES MARKET HIGHLIGHTS

  • The global SCS devices market was valued at more than $2.5bn in 2017 and is expected to grow at a double-digit CAGR of more than 13% over the next 5 years.
  • The US remains the largest SCS market, accounting for more than 75% of the total market in 2017, although regions outside the US such as the 5EU represent good growth potential.
  • The market will be driven by several factors, including the aging population and corresponding increase in diseases/injuries/trauma resulting in chronic, intractable pain (eg back/leg pain), solid clinical history, technological innovation, and growing awareness and usage of SCS technologies.
  • Technological trends and innovations include but are not limited to: expanding pain indications (eg to peripheral nerve targets), customizing and broadening pain coverage and precision, miniaturization/less invasive device technologies, elimination of paresthesia, lowering overall risk profile, improving ease of use/implantation, greater patient monitoring/tracking, and providing even higher, sustained pain relief. A future goal of SCS is eliminating surgery altogether.
Key Questions Answered
  • What is the value of the global SCS devices market? What is the expected growth over the next 5 years?
  • What is the expected market growth by major region of the world (US, 5EU, Japan, and RoW)?
  • What are the key drivers & limiters?
  • Technological trends?
  • Who are the leading competitors, estimated market share by region, and strategic growth strategies?


TABLE OF CONTENTS:
Executive Summary

i. Report overview
ii. Chronic intractable pain
iii. SCS devices
iv. SCS devices market
	a. Market drivers and limiters
	b. Technology trends
	c. Market share 
v. Methodology 
vi. Bibliography

Exhibit ES-1: Selected types of chronic pain, estimated US prevalence
Exhibit ES-2: Spinal cord stimulation devices, global market forecast ($m), 2017-22 
Exhibit ES-3: Spinal cord stimulation devices market, estimated share of revenues by region, 2017 
Exhibit ES-4: Spinal cord stimulation devices market, estimated global share by supplier, 2017 

1. Clinical Overview

1.1 Chronic pain 
1.2 Spinal cord, nerves, and the transmission of pain
1.3 The central nervous system versus peripheral nervous system
1.4 Pain statistics 
1.5 Cost of pain 
1.6 Pain treatment
1.7 Opioid abuse and deaths
1.8 Procedural therapies for treating pain 
1.9 Spinal cord stimulation 
1.10 Peripheral nerve stimulation 
1.11 Transcutaneous electrical nerve stimulation
1.12 Bibliography 

Exhibit 1-1: Diagram of the spine and spinal cord
Exhibit 1-2: The nervous system, including four types of nerves
Exhibit 1-3: Selected types of chronic pain, estimated US prevalence
Exhibit 1-4: The US opioid epidemic by numbers, 2016
Exhibit 1-5: Diagram of cardiac pacemaker implantation 
Exhibit 1-6: Basic diagram of SCS system implantation

2. Neuromodulation Technologies for the Treatment of Pain
 
2.1 Spinal cord stimulation systems 
	2.1.1 Abbott (St. Jude Medical) 
	2.1.2 Boston Scientific
	2.1.3 Medtronic 
	2.1.4 Nevro 
	2.1.5 Nuvectra
	2.1.6 Saluda Medical
	2.1.7 Stimwave
2.2 Emerging minimally invasive pain stimulation systems
	2.2.1 Autonomic Technologies 
	2.2.2 Bioness
	2.2.3 electroCore 
	2.2.4 Mainstay Medical
	2.2.5 NeuroMetrix 
	2.2.6 Neuros Medical
	2.2.7 SPR Therapeutics 
2.3 Clinical trial results: spinal cord stimulation
	2.3.1 Abbott/SUNBURST study 
	2.3.2 Abbott/TRIUMPH study 
	2.3.3 Boston Scientific/WHISPER study 
	2.3.4 Nevro/SENZA-RCT study 
	2.3.5 Medtronic/VECTORS study 
2.4 Technological trends
2.5 Primary research: SCS pain questionnaire to physicians
2.6 Primary research: KOL Insight Interview
2.7 Medtronic SCS product performance questionnaire
2.8 Reimbursement 
2.9 Risks 
2.10 Bibliography 

Exhibit 2-1: Selected leading spinal cord stimulation systems.
Exhibit 2-2: New/recently approved spinal cord stimulation and peripheral nerve stimulation devices, 2017-18 
Exhibit 2-3: BurstDR stimulation pain relief
Exhibit 2-4: St. Jude Medical Invisible Trial System 
Exhibit 2-5: Boston Scientific's new Spectra WaveWriter SCS System
Exhibit 2-6: Boston Scientific's original Precision Spectra System, designed with 32 contacts and 32 dedicated power sources
Exhibit 2-7: Medtronic's new Intellis SCS platform
Exhibit 2-8: Nevro's Senza SCS system
Exhibit 2-9: Nuvectra's Algovita SCS system
Exhibit 2-10: Saluda Medical's innovative closed-loop Evoke SCS System
Exhibit 2-11: Stimwave's Freedom SCS system
Exhibit 2-12: Selected new or emerging PNS/TENS devices
Exhibit 2-13: ATI Neurostimulator System for treating cluster headache
Exhibit 2-14: Bioness's StimRouter system for treating peripheral nerve pain
Exhibit 2-15: electroCore's externally applied gammaCore system for treating
chronic migraine and cluster headache
Exhibit 2-16: Mainstay Medical's ReActiv8 system
Exhibit 2-17: NeuroMetrix's high-power, proprietary wearable Quell device for
chronic pain relief 
Exhibit 2-18: Neuros Medical's implantable Altius system for peripheral nerve stimulation
Exhibit 2-19: SPR Therapeutics' SPRINT PNS system 

3. Spinal Cord Stimulation Devices Market

3.1 Market forecast: global
	3.1.1 Market forecast: US
	3.1.2 Market forecast: five major EU markets
	3.1.3 Market forecast: Japan
	3.1.4 Market forecast: RoW
	3.1.5 Market drivers and limiters
3.2 Competitive analysis
	3.2.1 Market share: global 
	3.2.2 Market share: by region
3.3 Corporate profiles
	3.3.1 Abbott
	3.3.2 Boston Scientific
	3.3.2 Medtronic
	3.3.3 Nevro
	3.3.4 Nuvectra
3.4 Bibliography 

Exhibit 3-1: Spinal cord stimulation devices, global market forecast ($m), 2017-22 
Exhibit 3-2: Spinal cord stimulation devices market, estimated share of revenues by region, 2017
Exhibit 3-3: Spinal cord stimulation devices market, forecast sales by region ($m), 2017-22
Exhibit 3-4: Spinal cord stimulation devices market, estimated global share by supplier, 2017 
Exhibit 3-5: Spinal cord stimulation devices market, estimated share by supplier and region, 2017

Appendix A: company listing


COMPANIES COVERED:

  1. Abbott Laboratories
  2. Autonomic Technologies, Inc.
  3. Bioness, Inc.
  4. Boston Scientific
  5. electroCore
  6. Mainstay Medical
  7. Medtronic plc
  8. NeuroMetrix
  9. Neuros Medical
  10. Nevro Corporation
  11. Nuvectra Corporation
  12. Saluda Medical
  13. SPR Therapeutics
  14. Stimwave LLC
Contact Us

Need help finding medtech research? Let us help you!